LA TRAGICOMEDIA DE LAS banderillaS el bichito: SE HA ESCRITO UN CRIMEN

Ya casi terminando:

Cerebral venous sinus thrombosis 2 weeks after first dose of SARS-CoV-2 mRNA vaccine: Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine - PubMed


A case of multiple thrombocytopenia and thrombosis ***owing vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2: A case of thrombocytopenia and multiple thromboses after vaccination with ChAdOx1 nCoV-19 against SARS-CoV-2 - PubMed


Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines: Vaccine-induced thrombotic thrombocytopenia: the elusive link between thrombosis and adenovirus-based SARS-CoV-2 vaccines - PubMed


Acute ischemic stroke revealing immune thrombotic thrombocytopenia induced by ChAdOx1 nCov-19 vaccine: impact on recanalization strategy: Acute Ischemic Stroke Revealing ChAdOx1 nCov-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia: Impact on Recanalization Strategy - PubMed


New-onset refractory status epilepticus after ChAdOx1 nCoV-19 vaccine: New-onset refractory status epilepticus ***owing the ChAdOx1 nCoV-19 vaccine - PubMed


Thrombosis with thrombocytopenia syndrome associated with el bichito-19 viral vector vaccines: Thrombosis with Thrombocytopenia Syndrome associated with viral vector el bichito-19 vaccines - PubMed


Pulmonary embolism, tras*ient ischemic attack, and thrombocytopenia after Johnson & Johnson el bichito-19 vaccine: Pulmonary embolism, tras*ient ischaemic attack and thrombocytopenia after the Johnson & Johnson el bichito-19 vaccine - PubMed


Thromboaspiration infusion and fibrinolysis for portomesenteric thrombosis after administration of the AstraZeneca el bichito-19 vaccine: Thromboaspiration and fibrinolysis infusion for portomesenteric thrombosis after AstraZeneca el bichito-19 vaccine administration - PubMed.


Spontaneous HIT syndrome: knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia: Spontaneous HIT syndrome: Knee replacement, infection, and parallels with vaccine-induced immune thrombotic thrombocytopenia - PubMed


Deep venous thrombosis (DVT) occurring shortly after second dose of SARS-CoV-2 mRNA vaccine: Deep vein thrombosis (DVT) occurring shortly after the second dose of mRNA SARS-CoV-2 vaccine - PubMed


Procoagulant antibody-mediated procoagulant platelets in immune thrombotic thrombocytopenia associated with SARS-CoV-2 vaccination: Antibody-mediated procoagulant platelets in SARS-CoV-2-vaccination associated immune thrombotic thrombocytopenia - PubMed.


Vaccine-induced immune thrombotic thrombocytopenia causing a severe form of cerebral venous thrombosis with high mortality rate: a case series: Vaccine Induced Immune Thrombotic Thrombocytopenia Causing a Severe Form of Cerebral Venous Thrombosis With High Fatality Rate: A Case Series - PubMed.


Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis: Procoagulant microparticles: a possible link between vaccine-induced immune thrombocytopenia (VITT) and cerebral sinus venous thrombosis - PubMed.


Atypical thrombosis associated with the vaccine VaxZevria® (AstraZeneca): data from the French network of regional pharmacovigilance centers: Atypical thrombosis associated with VaxZevria® (AstraZeneca) vaccine: Data from the French Network of Regional Pharmacovigilance Centres - PubMed.


Acute cerebral venous thrombosis and pulmonary artery embolism associated with the el bichito-19 vaccine: el bichito-19 vaccine-associated acute cerebral venous thrombosis and pulmonary artery embolism - PubMed.


Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage: Vaccine-induced thrombosis and thrombocytopenia with bilateral adrenal haemorrhage - PubMed.


Palmar digital vein thrombosis after Oxford-AstraZeneca el bichito-19 vaccination: Thrombosis of the palmar digital vein after Oxford-AstraZeneca el bichito-19 vaccination - PubMed.


Cutaneous thrombosis associated with cutaneous necrosis ***owing Oxford-AstraZeneca el bichito-19 vaccination: Cutaneous thrombosis associated with skin necrosis ***owing Oxford-AstraZeneca el bichito-19 vaccination - PubMed


Cerebral venous thrombosis ***owing el bichito-19 vaccination: Cerebral Venous Thrombosis ***owing el bichito-19 Vaccination - PubMed.


Lipschütz ulcers after AstraZeneca el bichito-19 vaccination: [Lipschütz Ulcers after the AstraZeneca el bichito-19 Vaccine] - PubMed.


Amyotrophic Neuralgia secondary to Vaxzevri vaccine (AstraZeneca) el bichito-19: Amyotrophic neuralgia secondary to Vaxzevri (AstraZeneca) el bichito-19 vaccine - PubMed


Thrombosis with thrombocytopenia after Messenger vaccine RNA-1273: Thrombosis With Thrombocytopenia After the Messenger RNA-1273 Vaccine - PubMed


Intracerebral hemorrhage twelve days after vaccination with ChAdOx1 nCoV-19: [Intracerebral haemorrhage twelve days after vaccination with ChAdOx1 nCoV-19] - PubMed


Thrombotic thrombocytopenia after vaccination with el bichito-19: in search of the underlying mechanism: Thrombotic Thrombocytopenia after el bichito-19 Vaccination: In Search of the Underlying Mechanism - PubMed


cobi19 (el bichito-19) Vaccine-induced immune thrombotic thrombocytopenia (VITT): cobi19 (el bichito-19) Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) - PubMed


Comparison of adverse drug reactions among four el bichito-19 vaccines in Europe using the EudraVigilance database: Thrombosis in unusual sites: Comparison of adverse drug reactions among four el bichito-19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites - PubMed


Immunoglobulin adjuvant for vaccine-induced immune thrombotic thrombocytopenia: Adjunct Immune Globulin for Vaccine-Induced Immune Thrombotic Thrombocytopenia - PubMed


Severe vaccine-induced thrombotic thrombocytopenia ***owing vaccination with el bichito-19: an autopsy case report and review of the literature: Vaccine-induced severe thrombotic thrombocytopenia ***owing el bichito-19 vaccination: a report of an autoptic case and review of the literature - PubMed.


A case of acute pulmonary embolism after immunization with SARS-CoV-2 mRNA: A Case of Acute Pulmonary Embolus after mRNA SARS-CoV-2 Immunization - PubMed


Neurosurgical considerations regarding decompressive craniectomy for intracerebral hemorrhage after SARS-CoV-2 vaccination in vaccine-induced thrombotic thrombocytopenia-VITT: Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT - PubMed


Thrombosis and SARS-CoV-2 vaccines: vaccine-induced immune thrombotic thrombocytopenia: Thrombosis and severe acute respiratory syndrome cobi19 2 vaccines: vaccine-induced immune thrombotic thrombocytopenia - PubMed.


Acquired thrombotic thrombocytopenic thrombocytopenic purpura: a rare disease associated with the BNT162b2 vaccine: Acquired thrombotic thrombocytopenic purpura: A rare disease associated with BNT162b2 vaccine - PubMed.


Immune complexes, innate immunity and NETosis in ChAdOx1 vaccine-induced thrombocytopenia: Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia - PubMed.


Sensory Guillain-Barré syndrome ***owing ChAdOx1 nCov-19 vaccine: report of two cases and review of the literature: https://pubmed.ncbi.nlm.nih.gov/34416410/.


Vogt-Koyanagi-Harada syndrome after el bichito-19 and ChAdOx1 nCoV-19 (AZD1222) vaccination: https://pubmed.ncbi.nlm.nih.gov/34462013/.


Reactivation of Vogt-Koyanagi-Harada disease under control for more than 6 years, after anti-SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34224024/.


Post-vaccinal encephalitis after ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34324214/


Neurological symptoms and neuroimaging alterations related to el bichito-19 vaccine: cause or coincidence?: https://pubmed.ncbi.nlm.nih.gov/34507266/


Fatal systemic capillary leak syndrome after SARS-COV-2 vaccination in a patient with multiple myeloma: https://pubmed.ncbi.nlm.nih.gov/34459725/


Polyarthralgia and myalgia syndrome after vaccination with ChAdOx1 nCOV-19: https://pubmed.ncbi.nlm.nih.gov/34463066/


Three cases of subacute thyroiditis after SARS-CoV-2 vaccination: post-vaccination ASIA syndrome: https://pubmed.ncbi.nlm.nih.gov/34043800/.


Facial diplegia: a rare and atypical variant of Guillain-Barré syndrome and the Ad26.COV2.S vaccine: https://pubmed.ncbi.nlm.nih.gov/34447646/


Association between ChAdOx1 nCoV-19 vaccination and bleeding episodes: large population-based cohort study: https://pubmed.ncbi.nlm.nih.gov/34479760/.


fulminant myocarditis and systemic hyperinflammation temporally associated with BNT162b2 el bichito-19 mRNA vaccination in two patients: https://pubmed.ncbi.nlm.nih.gov/34416319/.


Adverse effects reported after el bichito-19 vaccination in a tertiary care hospital, centered on cerebral venous sinus thrombosis (CVST): https://pubmed.ncbi.nlm.nih.gov/34092166/


Induction and exacerbation of subacute cutaneous lupus erythematosus erythematosus after mRNA- or adenoviral vector-based SARS-CoV-2 vaccination: https://pubmed.ncbi.nlm.nih.gov/34291477/


Petechiae and peeling of fingers after immunization with BTN162b2 messenger RNA (mRNA)-based el bichito-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34513435/


Hepatitis C bichito reactivation after el bichito-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34512037/


Bilateral immune-mediated keratolysis after immunization with SARS-CoV-2 recombinant viral vector vaccine: https://pubmed.ncbi.nlm.nih.gov/34483273/.


Immune-mediated thrombocytopenic purpura after Pfizer-BioNTech el bichito-19 vaccine in an elderly woman: https://pubmed.ncbi.nlm.nih.gov/34513446/


Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with the ChAdO × 1 nCov-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34474550/


Reactive arthritis after el bichito-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34033732/.


Two cases of Graves’ disease after SARS-CoV-2 vaccination: an autoimmune / inflammatory syndrome induced by adjuvants: https://pubmed.ncbi.nlm.nih.gov/33858208/


Acute relapse and impaired immunization after el bichito-19 vaccination in a patient with multiple sclerosis treated with rituximab: https://pubmed.ncbi.nlm.nih.gov/34015240/


Widespread fixed bullous drug eruption after vaccination with ChAdOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34482558/


el bichito-19 mRNA vaccine causing CNS inflammation: a case series: https://pubmed.ncbi.nlm.nih.gov/34480607/


Thymic hyperplasia after el bichito-19 mRNA-based vaccination with el bichito-19: https://pubmed.ncbi.nlm.nih.gov/34462647/


Acute disseminated encephalomyelitis ***owing vaccination against SARS-CoV-2: https://pubmed.ncbi.nlm.nih.gov/34325334/


Tolosa-Hunt syndrome occurring after el bichito-19 vaccination: https://pubmed.ncbi.nlm.nih.gov/34513398/


Systemic capillary extravasation syndrome ***owing vaccination with ChAdOx1 nCOV-19 (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34362727/


Immune-mediated thrombocytopenia associated with Ad26.COV2.S vaccine (Janssen; Johnson & Johnson): https://pubmed.ncbi.nlm.nih.gov/34469919/.


tras*ient thrombocytopenia with glycoprotein-specific platelet autoantibodies after vaccination with Ad26.COV2.S: case report: https://pubmed.ncbi.nlm.nih.gov/34516272/.


Acute hyperactive encephalopathy ***owing el bichito-19 vaccination with dramatic response to methylprednisolone: case report: https://pubmed.ncbi.nlm.nih.gov/34512961/


tras*ient cardiac injury in adolescents receiving the BNT162b2 mRNA el bichito-19 vaccine: https://pubmed.ncbi.nlm.nih.gov/34077949/


Autoimmune hepatitis developing after ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca): https://pubmed.ncbi.nlm.nih.gov/34171435/


Severe relapse of multiple sclerosis after el bichito-19 vaccination: a case report: https://pubmed.ncbi.nlm.nih.gov/34447349/


Lymphohistocytic myocarditis after vaccination with the el bichito-19 viral vector Ad26.COV2.S: https://pubmed.ncbi.nlm.nih.gov/34514078/


Hemophagocytic lymphohistiocytosis after vaccination with ChAdOx1 nCov-19: https://pubmed.ncbi.nlm.nih.gov/34406660/.


IgA vasculitis in adult patient after vaccination with ChadOx1 nCoV-19: https://pubmed.ncbi.nlm.nih.gov/34509658/


A case of leukocytoclastic vasculitis after vaccination with a SARS-CoV2 vaccine: case report: https://pubmed.ncbi.nlm.nih.gov/34196469/.


Onset / outbreak of psoriasis after Corona bichito ChAdOx1 nCoV-19 vaccine (Oxford-AstraZeneca / Covishield): report of two cases: https://pubmed.ncbi.nlm.nih.gov/34350668/
 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Solo los usuarios registrados pueden ver el contenido de este tema, mientras tanto puedes ver el primer y el último mensaje de cada página.

Regístrate gratuitamente aquí para poder ver los mensajes y participar en el foro. No utilizaremos tu email para fines comerciales.

Únete al mayor foro de economía de España

 
Volver